Navigation Links
NeuroAiD(TM), a Stroke Treatment Based on Traditional Chinese Medicine, More than Doubles the Chances of Achieving Independence after Stroke
Date:3/19/2013

SINGAPORE, March 19, 2013 /PRNewswire/ -- Authors of a medical paper published in this month's Cerebrovascular Diseases journal found that NeuroAiD™, developed by Moleac, significantly improves patients' independence after suffering a stroke compared to other control groups. During the studies stroke patients taking NeuroAiD™ were twice as likely able to take care of themselves and speak freely.  The study also showed that NeuroAiD™ improved patients' chances of performing daily activities after stroke.

Stroke is one of the leading causes of death worldwide and occurs every 2 seconds. Each year, 20 million people suffer from the devastating disease. There are only few effective, generally accepted and specific treatments for stroke, like thrombolytic treatment for highly selected patients. Therefore, there is an increasing need for multi-model therapies to help more patients recover quickly and effectively from stroke.

Herbal supplements have been demonstrated to have antioxidant, anti-inflammatory, and anti-glutamate effects, making them an attractive option to be investigated for stroke recovery. Thus, as Dr. Christopher Chen , one of the authors of the paper, says, "confirmation of the effectiveness of herbal supplements could have a great impact on stroke management". The paper updates the meta-analysis, published in Stroke journal in 2009 to include all clinical data available since 2009 on NeuroAiD™ and provides an overall assessment of the beneficial effects of NeuroAiD™ in improving functional and motor outcomes in the recovery after a stroke.

About Moleac

To address therapeutic gaps, Moleac has pioneered a new drug development approach, looking at sources of innovation from Traditional Medicines, hence shortening considerably drug development cycle time and investment to bring medicine to sufferers' unaddressed needs. Moleac's neurorestorative drug NeuroAiD™ reaches patients in more than 30 countries.

Contact

To learn more about the medical paper and for interview requests, please contact:

Ms Fahima Khail
Global Marketing and Product  Manager
Email: Fahima.Khail@moleac.com
Tel. No.: +65 6478 9430 Ext.: 124
Mobile No.: +65 8427 6702
Moleac Pte Ltd Helios #09-08, 11 Biopolis Way Singapore 138667
www.moleac.com


'/>"/>
SOURCE Moleac
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Niacin Causes Serious Unexpected Side-effects, but no Worthwhile Benefits, for Patients who are at Increased Risk of Heart Attacks and Strokes
2. Now Available in Fredericksburg: Painless Screening Exam To Help Prevent Heart Attacks, Strokes
3. Top New York City Cardiologist Dr. Steven Reisman to be Featured on Inside Edition to Discuss Mini-Strokes and Strokes
4. New "15 Every Hour" Campaign Spreads the Word on the Devastating Impact of AFib-Related Stroke
5. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
6. Masimos Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery
7. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
8. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
9. ICV Partners Establishes Dialysis Treatment Platform With Acquisition Of Atlantis Healthcare Group Puerto Rico, Inc.
10. Hands-On Treatment Improves Chronic Low Back Pain, Reduces Medication Use
11. A Revolutionary Treatment for Burns & Bone Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 Stem cells are primitive cells found ... and the capacity to differentiate into mature cell types ... the first mouse embryonic stem cells were derived from ... that the first culturing of embryonic stem cells from ... produced until 2006 As a result of these discoveries, ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... , Feb. 11, 2016   Health 2.0 ... of new health technologies, announced today " 10 Year ... in health tech over the past ten years.   ... nearly a decade, Health 2.0 has served as the ... and connected with thousands of technologies, companies, innovators, and ...
Breaking Medicine Technology:
(Date:2/12/2016)... MIAMI, FLA (PRWEB) , ... February 12, 2016 , ... ... free dental implants to their Miami dental office. Beginning in January, Miami Dental ... traditional titanium. Miami Dental Specialists are the first office to be chosen by the ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today ... , The print component of “Revolutionizing Cancer Care” is distributed within the February ... and Seattle, with a circulation of approximately 250,000 copies and an estimated readership ...
(Date:2/12/2016)... ... February 12, 2016 , ... Homeowners now have ... possibilities. CertainTeed, North America’s leading brand of building products, has improved upon its ... in the mobile version of the ColorView® Exterior Style and Color Selector. Created ...
(Date:2/12/2016)... ... 12, 2016 , ... Healthcare careers in the medical laboratory, nursing, and in ... website of healthcare staffing leader Aureus Medical Group during the month of January. Aureus ... therapy positions and in travel and direct hire opportunities in other allied health ...
(Date:2/12/2016)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... real facts surrounding all those Bible stories. For generations families have gathered to hear ... says there is more to these than just mere “stories”. , The article ...
Breaking Medicine News(10 mins):